P2Y12 Receptor Inhibitors in Acute Coronary Syndromes: What Is New on the Horizon? - Wikidata - wikimedia - TriplyDB

P2Y12 Receptor Inhibitors in Acute Coronary Syndromes: What Is New on the Horizon?

P2Y12 Receptor Inhibitors in Acute Coronary Syndromes: What Is New on the Horizon?

http://www.wikidata.org/entity/Q41511099

about

Personalized antiplatelet therapy with P2Y12 receptor inhibitors: benefits and pitfalls Reduced number of cardiovascular events and increased cost-effectiveness by genotype-guided antiplatelet therapy in patients undergoing percutaneous coronary interventions in the Netherlands.The Personalization of Clopidogrel Antiplatelet Therapy: The Role of Integrative Pharmacogenetics and Pharmacometabolomics.Pharmacogenomic Impact of CYP2C19 Variation on Clopidogrel Therapy in Precision Cardiovascular Medicine.

P2860

Q26775125-DB52894B-4E10-46FF-AE61-9C1C13E58DDB Q37289886-1C9A5CC1-F247-4800-9E02-7E6342BA0B3F Q39249688-11851A23-1F9C-4E92-9F8F-47432067F9A3 Q47554139-927ED958-FBBA-4958-AED8-F81DB0138995

P2860

P2Y12 Receptor Inhibitors in Acute Coronary Syndromes: What Is New on the Horizon?

http://www.wikidata.org/entity/Q41511099

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

P2Y12 Receptor Inhibitors in Acute Coronary Syndromes: What Is New on the Horizon?

@en

type

label

P2Y12 Receptor Inhibitors in Acute Coronary Syndromes: What Is New on the Horizon?

@en

prefLabel

P2Y12 Receptor Inhibitors in Acute Coronary Syndromes: What Is New on the Horizon?

@en

P1433

Q41511099-CC5BC8CA-8671-4625-BB13-F51AC4BDF07B

P1476

Q41511099-CF9471E7-9CC5-4103-98CC-BFAED15386EF

P2093

Q41511099-031E0167-5C21-4122-B866-2FD01F22FD16

Q41511099-20CF292E-83A5-4F50-B15B-96DE77BF3C15

P2860

Q41511099-00BC3D6C-2F7D-4E1F-84AD-B8BAF02353D8

Q41511099-0228766D-41D7-4B1E-BEA3-7B4E2B4BFF32

Q41511099-0252F90A-DF80-4C2F-972B-10A73527EB67

Q41511099-05A77D6B-0205-4DD6-A25D-36D013EFD363

Q41511099-064FFECB-C8C3-4B40-941E-43D3ED61F4E1

Q41511099-0AD60203-80B3-4C2A-8CC8-4F030FCEDA37

Q41511099-0B2A6C86-152D-49E0-9F00-27C60FBA4729

Q41511099-0E1AF38A-C427-4853-8060-DC68236A3C67

Q41511099-139582BE-B787-42A5-8B9C-A8A0D4FA662E

Q41511099-16BB3CB5-48DF-40DF-84B3-DEC2C969907C

P304

Q41511099-F94E759C-52C2-465C-908A-A5F903B53297

P31

Q41511099-C6B418FB-4D21-435A-9EEB-A648AFE4353B

P356

Q41511099-9BA3067A-652D-4932-A40E-946B20BF8EF4

P478

Q41511099-39E85245-7836-4143-A76A-AE8D5A6661F3

P577

Q41511099-EA85A5DA-43D7-4373-9665-348662DAB724

P5875

Q41511099-195E64CC-4324-437A-9545-D3C1C3109BC3

P698

Q41511099-2FE96870-37C3-48F5-BF77-8DCB6A2827F0

P932

Q41511099-68722537-7EF8-470E-9453-518A509FDEC1

P356

P1433

Cardiology Research and Practice

P1476

P2Y12 Receptor Inhibitors in Acute Coronary Syndromes: What Is New on the Horizon?

@en

P2093

Adriana Dana Oprea

http://www.w3.org/2001/XMLSchema#string

Wanda M Popescu

http://www.w3.org/2001/XMLSchema#string

P2860

ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC)

ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment el

The drug-drug interaction between proton pump inhibitors and clopidogrel

Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction

Aspirin resistance: position paper of the Working Group on Aspirin Resistance

Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial

Platelet reactivity in patients and recurrent events post-stenting: results of the PREPARE POST-STENTING Study

Contribution of gene sequence variations of the hepatic cytochrome P450 3A4 enzyme to variability in individual responsiveness to clopidogrel

Long-term care after percutaneous coronary intervention: focus on the role of antiplatelet therapy

Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation

P304

195456

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2013/195456

http://www.w3.org/2001/XMLSchema#string

P478

2013

http://www.w3.org/2001/XMLSchema#string

P577

2013-02-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236085482

http://www.w3.org/2001/XMLSchema#string

P698

23533940

http://www.w3.org/2001/XMLSchema#string

P932

3590496

http://www.w3.org/2001/XMLSchema#string